1-8 of 8
Kalevi Pyörälä
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria

Marjukka Hyvärinen, MSC, Qing Qiao, MD, PHD, Jaakko Tuomilehto, MD, PHD, Tiina Laatikainen, MD, PHD, Robert J. Heine, MD, PHD, Coen D.A. Stehouwer, MD, PHD, K. George M.M. Alberti, MD, PHD, Kalevi Pyörälä, MD, PHD, Björn Zethelius, MD, PHD, Birgitta Stegmayr, MD, PHD, for the DECODE Study Group
Journal: Diabetes Care
Diabetes Care 2009;32(2):348–354
https://doi.org/10.2337/dc08-1411
Published: 01 February 2009
View article titled, Hyperglycemia and Stroke Mortality: <subtitle>Comparison between fasting and 2-h glucose criteria</subtitle>
Open the PDF for Hyperglycemia and Stroke Mortality: <subtitle>Comparison between fasting and 2-h glucose criteria</subtitle> in another window
Includes: Supplementary data
Journal Articles

Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects

Auni Juutilainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2008;31(4):714–719
https://doi.org/10.2337/dc07-2124
Published: 01 April 2008
View article titled, Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects
Open the PDF for Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects in another window
Journal Articles

Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women: Response to Targher et al.

Auni Juutilainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2007;30(6):e52
https://doi.org/10.2337/dc07-0424
Published: 01 June 2007
View article titled, Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women: <subtitle>Response to Targher et al.</subtitle>
Open the PDF for Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women: <subtitle>Response to Targher et al.</subtitle> in another window
Journal Articles

Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes

Minna Soinio, MD, Jukka Marniemi, PHD, Markku Laakso, MD, Kalevi Pyörälä, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD
Journal: Diabetes Care
Diabetes Care 2007;30(3):523–528
https://doi.org/10.2337/dc06-1682
Published: 01 March 2007
View article titled, Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes
Open the PDF for Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes in another window
Journal Articles

Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women

Auni Juutilainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2007;30(2):292–299
https://doi.org/10.2337/dc06-1747
Published: 01 February 2007
View article titled, Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women
Open the PDF for Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women in another window
Journal Articles

Type 2 Diabetes as a “Coronary Heart Disease Equivalent”: An 18-year prospective population-based study in Finnish subjects

Auni Juutilainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2005;28(12):2901–2907
https://doi.org/10.2337/diacare.28.12.2901
Published: 01 December 2005
View article titled, Type 2 Diabetes as a “Coronary Heart Disease Equivalent”: <subtitle>An 18-year prospective population-based study in Finnish subjects</subtitle>
Open the PDF for Type 2 Diabetes as a “Coronary Heart Disease Equivalent”: <subtitle>An 18-year prospective population-based study in Finnish subjects</subtitle> in another window
Includes: Supplementary data
Journal Articles

Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk

Auni Juutilainen, MD, Saara Kortelainen, MD, Seppo Lehto, MD, Tapani Rönnemaa, MD, Kalevi Pyörälä, MD, Markku Laakso, MD
Journal: Diabetes Care
Diabetes Care 2004;27(12):2898–2904
https://doi.org/10.2337/diacare.27.12.2898
Published: 01 December 2004
View article titled, Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk
Open the PDF for Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk in another window
Journal Articles

Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)

Kalevi Pyörälä, MD, Christie M. Ballantyne, MD, Barry Gumbiner, MD, Michael W. Lee, PHD, Arvind Shah, PHD, Michael J. Davies, PHD, Yale B. Mitchel, MD, Terje R. Pedersen, MD, John Kjekshus, MD, for the Scandinavian Simvastatin Survival Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(7):1735–1740
https://doi.org/10.2337/diacare.27.7.1735
Published: 01 July 2004
View article titled, Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome: <subtitle>Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S) </subtitle>
Open the PDF for Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome: <subtitle>Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S) </subtitle> in another window